Karyopharm Therapeutics
Karyopharm Therapeutics Logo
Logos are displayed for identification only. Logokit is not affiliated with, endorsed by, or sponsored by the companies shown.
About Karyopharm Therapeutics
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company specializing in the discovery, development, and commercialization of novel drugs targeting nuclear export for the treatment of cancer. The company is a leader in Selective Inhibitor of Nuclear Export (SINE) technology, focusing on the inhibition of exportin 1 (XPO1) to address oncogenesis. Its lead product, XPOVIO, is approved for multiple myeloma and diffuse large B-cell lymphoma, and the company is advancing additional compounds for hematological and solid tumor malignancies. Karyopharm serves patients in the United States and internationally.
Address
85 Wells Avenue, 2nd Floor, Suite 210
Newton, 02459-3298
United States
Year founded
2008
Number of employees
200-300
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Add Karyopharm Therapeutics logo and brand data to your app or website
Embed this logo using a simple HTML tag, or access structured brand data with a single call to our API.
<img src="https://img.logokit.com/karyopharm.com" />
Report inaccurate data
Request an update to help us keep the brand up-to-date.
